D-dopachrome decarboxylase (89-97)

D-dopachrome decarboxylase

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-147

Synonyms/Alias:D-dopachrome decarboxylase (89-97)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
LALGQDRIL
Areas of Interest
Antigen-presenting Cells; Cancer Research

D-dopachrome decarboxylase (89-97) is a synthetic peptide fragment derived from the C-terminal region of the D-dopachrome decarboxylase enzyme, a member of the tautomerase superfamily. As a biologically relevant peptide, it represents a specific sequence within the larger protein that is implicated in the enzymatic conversion of D-dopachrome to 5,6-dihydroxyindole, a key step in melanin biosynthesis and catecholamine metabolism. This peptide is of interest in biochemical research for its structural, functional, and interactional properties, providing a focused tool for dissecting the activities and regulatory mechanisms of the parent enzyme. Its defined sequence enables detailed studies on protein-peptide interactions, epitope mapping, and enzymatic function, making it a valuable asset in peptide-related research and molecular biology.

Enzyme mechanism studies: Researchers utilize the D-dopachrome decarboxylase (89-97) peptide to elucidate the catalytic mechanism and substrate recognition features of the full-length enzyme. By isolating this specific region, scientists can investigate its role in substrate binding or catalysis, helping to define which amino acid residues are critical for enzymatic activity. Such studies are essential for understanding how structural motifs within the enzyme contribute to its function and may provide insights into the modulation of tautomerase activity in physiological and pathological contexts.

Protein-protein interaction mapping: The peptide serves as a model probe for identifying interaction partners of D-dopachrome decarboxylase, particularly those that recognize or bind the C-terminal domain. By incorporating the (89-97) sequence into binding assays, pull-down experiments, or surface plasmon resonance studies, researchers can map the interaction landscape of the enzyme. This approach enables the discovery of novel regulatory proteins or cofactors, facilitating a deeper understanding of the enzyme's role within complex cellular networks.

Epitope characterization and antibody development: The defined amino acid sequence of D-dopachrome decarboxylase (89-97) provides a precise epitope for generating and validating antibodies specific to the enzyme's C-terminal region. Such antibodies are invaluable tools for immunodetection, immunoprecipitation, and localization studies, allowing researchers to track endogenous or recombinant enzyme in diverse biological samples. The use of this peptide in immunological assays supports the development of highly specific reagents for research applications.

Peptide structure-activity relationship analysis: The (89-97) fragment is frequently employed in structure-activity relationship (SAR) studies to assess how specific sequence motifs contribute to the biological activity of D-dopachrome decarboxylase. By synthesizing analogues or introducing modifications within this peptide, scientists can systematically evaluate the impact of individual residues on conformation, stability, and functional properties. Such SAR analyses are fundamental for rational peptide design and for advancing the understanding of sequence-function relationships in enzyme biology.

Analytical method development: The unique sequence of the D-dopachrome decarboxylase (89-97) peptide makes it an effective standard or reference material in mass spectrometry and chromatographic analyses. Its defined molecular characteristics allow for calibration, method validation, and assay optimization in proteomics workflows. Employing this peptide as a reference supports the accurate quantification and identification of related protein fragments in complex biological samples, thereby enhancing analytical reliability and reproducibility in peptide-centric research.

Source#
Homo sapiens (human)
Epitope
89-97
Restricting HLA
HLA-A2
References
Kwasi Antwi; Mol Immunol 2009

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Analysis ServicesPeptide Modification ServicesEpitope Mapping ServicesCustom Conjugation ServicePeptide CDMOPeptide Nucleic Acids SynthesisPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers